Top execs leave Micap as losses mount
UK microencapsulation specialist Micap has seen the departure of both chief executive Michael Brennand and non-executive chairman Ian Gowrie Smith in a bid to cut the executive payroll.
Archives for September 20, 2005
New drugs, formulations driving US packaging market
The US market for pharmaceutical packaging will grow by nearly a third between 2004 and 2011, driven by the increasing demands placed on packaging by biologic drugs and novel drug delivery formulations, according to consulting firm Frost & Sullivan.
Eisai taps India for manufacturing expertise
Eisai has become the first Japanese drugmaker to set up a dedicated subsidiary in India in order to tap into local expertise in manufacturing and research, according to local press reports.
FDA sets out draft cGMPs for PET drugs
The US Food and Drug Administration (FDA) has drafted a current Good Manufacturing Practice (cGMP) regulation for the production of drugs used in positron emission tomography (PET), a diagnostic tool.
CFO resigns from troubled Andrx
US generics company Andrx, currently in the throes of an investigation into its manufacturing procedures by the Food and Drug Administration, announced the resignation of chief financial officer John Hanson.
Beckman Coulter launches integrated cytometry solution
Beckman Coulter has introduced its integrated cytometry solution (ICS), which simplifies and automates customer processes to improve productivity. The solution. becomes the first integrated system to offer laboratory information system (LIS) connectivity.
Euroscreen awarded US patent on GPC receptor
Euroscreen has announced the issuance of a US patent, which covers the use of a human G-protein-coupled receptor (GPCR) human P2Y13. The patent protects screening processes using this receptor to find compounds that modulate its activity, thus having...
Report blasts 'hype' over personalised medicines
According to a recent report, pharmacogenetics is unlikely to become a reality within the next 15-20 years having been 'hyped' by the media, who are unaware of the many gaps in current understanding of how genetics relates to the causes of disease.